CiteULike: guhjy's Hegele:RA [8 articles]

Kinase mutations in human disease: interpreting genotype|[ndash]|phenotype relationships

Nature Reviews Genetics, Vol. 11, No. 1. (01 January 2010), pp. 60-74.

by Piya Lahiry, Ali Torkamani, Nicholas J. Schork, Robert A. Hegele

posted to kinase by guhjy on 2009-12-19 10:12:01 as

along with 1 person daforerog

Hypertriglyceridemia: phenomics and genomics.

Molecular and cellular biochemistry, Vol. 326, No. 1-2. (June 2009), pp. 35-43.

by R. A. Hegele, R. L. Pollex

posted to genetics tg by guhjy on 2009-07-18 10:31:23 as

Gene-gene and gene-environment interactions: new insights into the prevention, detection and management of coronary artery disease.

Genome medicine, Vol. 1, No. 2. (26 February 2009)

by Matthew B. Lanktree, Robert A. Hegele

posted to cv epistasis gene-environment genetics by guhjy on 2009-04-29 06:55:02 as

Update on the genetics of stroke and cerebrovascular disease 2007.

Stroke; a journal of cerebral circulation, Vol. 39, No. 2. (February 2008), pp. 252-254.

by R. A. Hegele, M. Dichgans

posted to genetics stroke by guhjy on 2008-12-06 04:39:27 as

Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.

Journal of diabetes and its complications, Vol. 21, No. 3. (n 2007), pp. 166-171.

by R. L. Pollex, M. Mamakeesick, B. Zinman, S. B. Harris, R. A. Hegele, A. J. Hanley

posted to dn ppar snp by guhjy on 2008-05-24 10:08:15 as

Hypertriglyceridemia: its etiology, effects and treatment.

CMAJ, Vol. 176, No. 8. (10 April 2007), pp. 1113-1120.

by G. Yuan, K. Z. Al-Shali, R. A. Hegele

posted to no-tag by guhjy on 2008-02-28 03:06:30 as

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Can J Cardiol, Vol. 23, No. 7. (15 May 2007), pp. 539-550.

posted to no-tag by guhjy on 2008-02-14 08:42:44 as

Is raising HDL a futile strategy for atheroprotection?

Nature Reviews Drug Discovery, Vol. 7, No. 2., pp. 143-155.

by Tisha Joy, Robert A. Hegele

posted to no-tag by guhjy on 2008-02-04 05:08:37 as

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

	Kinase mutations in human disease: interpreting genotype\|[ndash]\|phenotype relationships [My Copy] Nature Reviews Genetics, Vol. 11, No. 1. (01 January 2010), pp. 60-74. by Piya Lahiry, Ali Torkamani, Nicholas J. Schork, Robert A. Hegele posted to kinase by guhjy on 2009-12-19 10:12:01 as along with 1 person daforerog
	Hypertriglyceridemia: phenomics and genomics. [My Copy] Molecular and cellular biochemistry, Vol. 326, No. 1-2. (June 2009), pp. 35-43. by R. A. Hegele, R. L. Pollex posted to genetics tg by guhjy on 2009-07-18 10:31:23 as
	Gene-gene and gene-environment interactions: new insights into the prevention, detection and management of coronary artery disease. [My Copy] Genome medicine, Vol. 1, No. 2. (26 February 2009) by Matthew B. Lanktree, Robert A. Hegele posted to cv epistasis gene-environment genetics by guhjy on 2009-04-29 06:55:02 as
	Update on the genetics of stroke and cerebrovascular disease 2007. [My Copy] Stroke; a journal of cerebral circulation, Vol. 39, No. 2. (February 2008), pp. 252-254. by R. A. Hegele, M. Dichgans posted to genetics stroke by guhjy on 2008-12-06 04:39:27 as
	Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes. [My Copy] Journal of diabetes and its complications, Vol. 21, No. 3. (n 2007), pp. 166-171. by R. L. Pollex, M. Mamakeesick, B. Zinman, S. B. Harris, R. A. Hegele, A. J. Hanley posted to dn ppar snp by guhjy on 2008-05-24 10:08:15 as
	Hypertriglyceridemia: its etiology, effects and treatment. [My Copy] CMAJ, Vol. 176, No. 8. (10 April 2007), pp. 1113-1120. by G. Yuan, K. Z. Al-Shali, R. A. Hegele posted to no-tag by guhjy on 2008-02-28 03:06:30 as
	The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. [My Copy] Can J Cardiol, Vol. 23, No. 7. (15 May 2007), pp. 539-550. by N. A. Khan, B. Hemmelgarn, R. Padwal, et al.P. Larochelle, J. L. Mahon, R. Z. Lewanczuk, F. A. McAlister, S. W. Rabkin, M. D. Hill, R. D. Feldman, E. L. Schiffrin, N. R. Campbell, A. G. Logan, M. Arnold, G. Moe, T. S. Campbell, A. Milot, J. A. Stone, C. Jones, L. A. Leiter, R. I. Ogilvie, R. J. Herman, P. Hamet, G. Fodor, G. Carruthers, B. Culleton, K. D. Burns, M. Ruzicka, J. deChamplain, G. Pylypchuk, N. Gledhill, R. Petrella, J. M. Boulanger, L. Trudeau, R. A. Hegele, V. Woo, P. McFarlane, R. M. Touyz, S. W. Tobe, posted to no-tag by guhjy on 2008-02-14 08:42:44 as
	Is raising HDL a futile strategy for atheroprotection? [My Copy] Nature Reviews Drug Discovery, Vol. 7, No. 2., pp. 143-155. by Tisha Joy, Robert A. Hegele posted to no-tag by guhjy on 2008-02-04 05:08:37 as

guhjy's Hegele:RA [8 articles] Export Sort

guhjy's tags

ckd	1742
rct	1204
dn	1162
cancer	1066
dm	1065
ma	979
cv	932
hd	859
tgfb	854
snp	772
ros	702
bp	644
kidney	524
meta-analysis	516
mouse	507
uae	501
stats	480
software	466
pt	455
genetics	450
mirna	450
proteomics	414
mortality	411
rat	401
fbl	385
inflammation	378
tw	377
1	367
mtor	362
proteinuria	356
pcr	353
akt	350
mc	348
db	337
acei	335
gdl	332
inhibitor	329
irs	328
test	325
method	325
urine	320
apoptosis	320
arb	317
age	316
aging	315
ms	310
hcv	306
aii	304
r	294
hg	292
biomarker	287
pi3k	283
ppi	282
bias	277
bayes	275
aki	272
gwa	270
emt	267
s6k	266
nutrition	255
rnai	252
egfr	252
ub	248
p53	246
fibrosis	242
erk	237
obesity	236
smad	233
cox	229
drug	225
pbmc	223
hcc	216
hypoxia	214
metab	214
gn	210
nfkb	208
herb	204
stz	199
collagen	196
albumin	189
lc	187
hif	186
pkc	181
pubmed	179
longitudinal	179
lmm	178
p38	176
gfr	174
ua	171
epigenetics	169
bioinf	167
japan	166
power	163
cea	163
gender	162
rage	162
dna-damage	162
lead	160
cadmium	159
genomics	155
book	154
ref	152
ctgf	150
vitamin-d	148
stata	147
liver	147
mt	146
company	146
network	146
diet	138
screening	137
rt	136
phosphorylation	135
seq	133
no	132
go	128
cell-cycle	128
esrd	128
stat	128
kinase	128
pathway	127
protein	127
insulin	125
systems-biology	124
statin	121
lipid	119
creatinine	117
proliferation	113
senescence	112
mapk	109
nox	109
imaging	107
podocyte	107
tnf	106
hypertrophy	104
fish	104
cad	103
regression	103
p21	102
pd	102
gfr-formula	102
case-control	102
pparg	101
imputation	101
multiplicity	100
ampk	99
observational	98
sirt	97
ko	97
rx	96
pediatric	96
methylation	96
cloning	96
plasmid	96
at1	96
recurrent	94
src	93
blood	93
betel	93
chf	92
gene-therapy	92
nhanes	91
review	91
anemia	89
immunity	89
website	89
phenotype	88
diagnosis	87
autophagy	87
lr	86
toxicology	86
uti	85
epo	84
cytokine	84
ebm	84
china	83
p	82
ca	82
environment	82
cachexia	81
oat	81
nonp	81
gout	80
hapmap	80
primer	78
qms	77
signaling	76
egf	75
foxo	74
ace	73
missing	73
eif	73
gpcr	73
col4	73
promoter	73
4ebp	72
eqtl	72
stone	72
lpd	72
gene-list	72
cox2	72
hts	72
surrogate	72
mv	71
p-value	71
salt	70
jnk	70
metformin	69
phd	69
mgo	69
uuo	67
glycemia	67
uncertainty	66
ifn	65
mirna-target	65
enddysf	65
normalization	65
chinese	65
pe	65
tin	65
shc	64
pla2	64
association	64
hsp	64
causation	63
acid-base	63
yeast	63
llcpk1	63
translation	63
2dge	63
pai1	62
pdgf	62
me	62
simulation	62
smoking	62
nrk49f	62
avf	61
confounding	61
oglcnac	61
mmp	61
vegf	61
ptm	61
melamine	60
sas	60
cost	60
crp	60
outcome	60
change	60
infection	60
pld	60
oral	59
hk2	59
fluorescence	58
rho	58
alcohol	58
urate-transporter	57
robust	57
model-selection	57
pls	57
cyclin-d1	57
calibration	56
rapamycin	56
achr	56
aceiarb	56
semantic	56
estrogen	55
ace2	55
ncrna	55
competing-risk	55
goldstd	55
ratio	55
stem-cell	55
bone	54
function	54
ckd-progression	54
workflow	54
iron	54
k	53
std	53
renoprotection	53
il6	53
dipstick	53
hsc	53
histone	52
p27	52
tf	52
atm	52
fgf	52
qc	52
dimerization	52
hdac	52
normoalbuminuria	51
lod	51
epidemiology	51
hepatocyte	51
pth	51
ab	51
arsenic	50
graph	50
matlab	50
risk-ratio	50
wnt	50
mercury	50
reasoning	50
adpkd	50
klotho	49
gene-environment	49
antibiotics	49
pdk	49
epistasis	49
nrk52e	48
ngal	48
ukm	48
ffpe	48
core-curriculum	48
irs1	48
breakpoint	48
endothelium	48
spot-urine	47
mtorc1	47
enos	47
pooling	47
joint-model	47
ras	47
aldosterone	47
fdr	46
cystatin	46
dub	46
hgf	46
protein-microarray	46
metal	46
aspirin	46
biosensor	45
prevention	45
tgfbr	45
semip	45
fgf23	45
er-stress	45
writing	45
dbdb	45
diuretics	44
ccb	44
mesangial	44
ecm	44
variability	44
sumo	44
interaction	44
ancova	44
design	43
cnv	43
klf	43
bia	43
na	43
sle	43
stroke	42
roc	42
catenin	42
icu	42
agreement	42
vsmc	42
asia	42
good	42
bmi	42
proteasome	41
gene-targeting	41
fuzzy	41
fibronectin	41
qtl	41
sage	40
hyperfiltration	40
risk	40
tlr	40
wga	40
tea	40
alignment	40
urinalysis	39
ap1	39
dry-bw	39
igf	39
angiogenesis	39
rca	39
coffee	39
protein-complex	39
mtorc2	38
antisense	38
igan	38
rsk	38
gsk3	38
myc	38
rvh	38
emr	38
omics	38
propensity	37
bh4	37
gsk	37
snx	37
haplotype	37
hematuria	37
megalin	37
adenosine	37
fabp	37
adh	37
glut	37
cardiorenal	36
web20	36
s100b	36
animal	36
il1	36
exercise	36
inflammasome	36
reverse-epidemiology	35
candidate-gene	35
cre	35
adduct	35
calcification	35
threshold	35
chemogenomics	35
subgroup	35
creb	35
sp1	35
annotation	35
attrition	34
pka	34
pathology	34
msm	34
cross-species	34
pp2a	34
effect-size	34
sglt	34
sepsis	34
igf1	34
nephrotoxicity	34
ecology	33
bmp	33
et	33
cage	33
sarcopenia	33
zeb	33
rtk	33
integrin	33
ns	33
macrophage	32
steroid	32
addgene	32
end-point	32
set	32
browser	32
aa	32
text-mining	32
ai	32
zfn	32
affy	32
orbitrap	32
fc	32
agt	31
abp	31
family	31
blast	31
gllamm	31
heritability	31
nutrient	31
emsa	31
risk-difference	31
silac	31
acidosis	31
transactivation	31
frailty	31
hospitalization	31
cr	31
reporter	30
s100	30
staging	30
membrane-protein	30
notch	30
knockout	30
gsh	30
geo	30
transporter	30
carcinogen	30
pten	30
mw	30
grn	30
virus	29
validation	29
human	29
nicotinic	29
sgk	29
perindopril	29
ub-ligase	29
renin	29
extraction	29
3	29
thesis	29
gee	28
time-dependent	28
mutagenesis	28
hplc	28
muscarinic	28
scaling	28